Jeffrey S Farrow
CIK 1405253 · See Remarks · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.95M
Companies
5
Total Filings
52
Lifetime Open-Market Net
-$5.75M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACHV | Director | — | $5.52 | — | $0 | 1 | 2026-06-02 |
| TARS | See Remarks | 47,635 | $61.95 | $2.95M | -$1.45M | 10 | 2026-03-19 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | Chief Financial Officer | 0 | $68.49 | $0 | -$4.30M | 29 | 2022-10-06 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | CFO | 0 | — | — | $0 | 7 | 2015-05-08 |
| RENOVIS INC (RNVS) Delisted | V.P., Finance and CAO | 62,286 | — | — | $0 | 3 | 2008-02-12 |
Recent Filings · Page 2 of 6
52 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-26 | TARS | Grant (A) | — | $0 | EDGAR |
| 2022-10-06 | Global Blood Therapeutics, Inc. (GBT) Delisted | Disp (D) | −26,739 | $0 | EDGAR |
| 2022-09-29 | Global Blood Therapeutics, Inc. (GBT) Delisted | Exer (M) | +23,653 | $387.9K | EDGAR |
| 2022-09-06 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | −28,355 | -$2.27M | EDGAR |
| 2022-08-03 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +4,019 | -$68.9K | EDGAR |
| 2022-03-03 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +1,448 | -$39.3K | EDGAR |
| 2022-02-03 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +4,514 | -$132.2K | EDGAR |
| 2021-09-24 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +4,666 | -$119.0K | EDGAR |
| 2021-09-03 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +1,392 | -$40.9K | EDGAR |
| 2021-08-03 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +4,666 | -$119.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.